Differential effects of wake promoting drug modafinil in aversive learning paradigms

Abstract

Modafinil (MO) an inhibitor of the dopamine transporter was initially approved to treat narcolepsy, a sleep related disorder in humans. One interesting "side-effect" of this drug, which emerged from preclinical and clinical studies, is the facilitation of cognitive performance. So far, this was primarily shown in appetitive learning paradigms, but it is yet… (More)
DOI: 10.3389/fnbeh.2015.00220

Topics

5 Figures and Tables

Slides referencing similar topics